Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study

Recruiting now · Not applicable

Conditions studied: Crohn Disease, Recurrence

In brief

The postoperative recurrence of Crohn's diseases (CD) remains high. Stapled anti-mesenteric functional end-to-end anastomosis was safe for CD patients. Its impact on the postoperative recurrence of CD was unknown. Whether it is superior than the conventional anastomosis (stapled antimesenteric isoperistaltic side-to-side anastomosis) needs explored. The trial aims to compare the different impacts of the two antimesenteric anastomosis configurations on the anastomotic recurrence following bowel resection.

Key facts

Study ID

NCT05658081

Run by

Jinling Hospital, China

People needed

236

Starts

2022-12-08

Expected to finish

2029-12-01

Last updated by the study team

2022-12-20

Who can join

Age: 16 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients with Crohn's disease needing bowel resection and anastomosis;
• ileocolic anastomosis；
• written consent acquired

You may not qualify if…

• patients underwent enterostomy;
• small bowel anastomosis;
• anticipating other trial.

Where it is running

• Department of General Surgery, Jinling hosptal,Medical School of Nanjing University — Nanjing, Jiangsu, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.